[Differentiation of functional disturbances of the central nervous system evoked by 6-aminonicotinamide, an antimetabolite of nicotinamide].
D000818:Animals; D000963:Antimetabolites; D001786:Blood Glucose; D001831:Body Temperature / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D005116:Extrapyramidal Tracts / Q000187:drug effects; D005260:Female; D006591:Hexobarbital / Q000494:pharmacology; D006943:Hyperglycemia / Q000139:chemically induced; D009069:Movement Disorders / Q000139:chemically induced*; D009128:Muscle Spasticity / Q000139:chemically induced*; D009536:Niacinamide / Q000008:administration & dosage; D051381:Rats
D000963:Antimetabolites; D001786:Blood Glucose; D009536:Niacinamide; D006591:Hexobarbital
Zur Differenzierung der durch 6-Aminonicotinamid, einem Antimetaboliten des Nicotinamids, hervorgerufenen zentralnervösen Funktionsstörungen.